This year, we're focusing on how to adapt to a new world of pharma supply chains through collaboration, change and agility.
We’re addressing the challenges and impact that COVID-19 has on the pharma supply chain, optimizing your end-to-end supply chain, introducing specific content tracks for senior executive functions and more.
Our interactive discussion groups and collaborative exercises are designed to help stakeholders break down silos across the supply chain and will address overlapping functional challenges.
Download the official agenda to see what else we have in store for you on September 21-25.
For over a decade, we at Cold Chain Global Forum have been dedicated to connecting and educating supply chain leaders from across the biopharma world from small, biotech startups to publicly traded Big Pharma manufacturers. In an effort to shed light on where the industry is headed in 2019, we surveyed 150+ life sciences logistics leaders on:
The following is a summary of what we learned along with expert analysis from our 2019 CCGF advisory board.
If you would like a copy sent directly to you, please contact us here.
View our event trailer and see first hand what its like to attend Cold Chain Global!
For those just starting out in temperature controlled supply, it can seem like a daunting task.
With a complex vendor landscape, pressing operational challenges and a multitude of risks factors, it is far from an easy project.
To help, we spoke to Kevin Hickman, Senior Manager of Supply Chain Distribution at Gilead Sciences. With over 26 years of experience in commercial and clinical pharma and biopharma transport management, he shares the cold chain critical success factors you need to know.
By now, the practices and procedures in managing a temperature-controlled supply chain for life sciences products have been well-established: there are international standards to follow; there are various certifications for vendor services; and there are a multitude of vendors, operating in most of the world, experienced in managing these products. That being said, there is also wide variability in what policies a manufacturer will follow, and how the terms of supply chain contracts will be written. To an unusually intense degree, upper management at many life sciences companies look critically at supply chain contracts: the cheaper the better, in this view. So there is yet another dynamic of weighing the cost of service against its quality.
It’s not a bad idea—when time and resources are available—to re-evaluate supply chain strategy for already-commercial products. Technology and vendor services are in a continual state of progress, and the economics of supply chain activities such as transportation modes and warehousing capacities change over time. So, the strategic evaluation isn’t a one-time exercise only when a product is about to be launched.
The following article by Nick Basta, Editor in Chief, Managing Partner and Founder of Pharmaceutical Commerce, lists out the factors that should go into every evaluation of supply chain options. The range of factors will vary widely from a multiproduct, multinational life sciences company, to a startup bringing one or a handful of products to market—and even the ability of the manufacturer to manage its own supply chain, versus outsourcing it to a third-party logistics provider (3PL). If you’ve seen one supply chain strategy, as the saying goes, you’ve seen one supply chain strategy.
If you would like a copy sent directly to you, please contact us here.
Going green is no longer a gimmick, and there is money to be made. However, what are the challenges for the industry moving forward? What will ultimately be a competitive advantage for pharma companies and supply chain stakeholders in the next 10 years?
The majority of the world is realizing that burning fossil fuels is no longer a “free for all” game, and that we need to start moving towards alternative energy sources sooner than later or face disastrous consequences for our environment. More importantly, regulators around the world have started to clamp down on traditional ‘dirty’ sources of energy.
This provocative session will explore how both pharma companies and the their supply chain partners will need to start exploring alternative transportation, and push 3PLs and other shippers to start addressing the fact that moving around trillions of tons of goods without reducing emissions might soon become unsustainable.
Presentation by Eugenio Filippi, Head of Manufacturing, Vienna, Austria Takeda Pharmaceuticals Company Limited
Implementing technical data and authenticating the life history of a product can improve supply chain security and streamline processes. Eli Lilly is using an effective stability budget for unplanned excursions and testing the capability of a product that is shipped around the world across a multitude of suppliers, regulations and patients.
Presentation by K. Nicole Harter Consultant Quality Assurance – Global Marketing Affiliates and Global Logistics Eli Lilly and Company
Eli Lilly partners with AeroSafe Global to Reduce their Cold Chain Total Cost of Ownership When considering a cold chain packaging partner, Eli Lilly demonstrates how including operations, warehouse, logistics and compliance costs in the Total Cost of Ownership results is a more responsible approach. In utilizing AeroSafe Global’s “Cold Chain as a Service”, Eli Lilly was able to benefit from the highest performing solutions while simultaneously reducing costs and improving sustainability.
Presentation by Christopher C. Lyons, Consultant Engineer, Eli Lilly and Company and Mike Mondo VP, Sales ,Aerosafe Global
Blockchain will provide an excellent framework and foundation to give the end to end visibility with the highest level of trust. Within a closed blockchain, everyone that is part of the blockchain will have total visibility throughout the blocks. If any data happens to change, immediate visibility will be available in the distributed ledger.
Presentation by Dean Croke Board Member Blockchain in Transportation Alliance (BiTA)
When you have a company that sells globally, it is challenging to make sure products meet regulatory requirements in different countries. The presentation explores:
Presentation by Cheyenne Similien, Quality Systems Engineer, Sartorius Stedim Bio Tech
AstraZeneca recently set up a global logistics function including process control and a Center of Excellence. Learn about the company’s journey and their future plans for 2025.
Presentation by Mark Everitt, CSCP Qualification Engineer, AstraZeneca Pharmaceuticals
We sat down with John Crowley, Chairman and CEO of Amicus Therapeutics this fall to discuss
The pharmaceutical industry is witnessing a period of high innovation, with new technologies emerging set to drastically impact the way we operate the supply chain.
The proposed applications for drones, artificial intelligence, data analytics and blockchain are numerous. Currently, though, application has been fragmented as people set out to explore this new technology without regulatory guidance or best practices.
In this report, we share a framework to guide your implementation and evaluation of new technology for the supply chain. We also offer insight from those who have made an innovative change to their supply chain, including an exclusive case study on the latest ambulance drone technology.
There are few things in life more frightening than a cancer diagnosis. With that in mind, ensuring that gene & cell therapy supply chains are as expedient and effective as possible. Considering the complex and time-sensitive nature of such supply chains, this can be incredibly challenging.
To get you started on your own Car-T logistics journey, we created this interactive presentation that walks you through the stages, challenges and opportunities associated with building a resilient and customer-centered Car-T supply chain.
The pharmaceutical supply chain requires a myriad of partners to work as a cohesive unit. However, this is not always the case. Most companies have relationships built between different stakeholders at different times, competing agendas leadings to a variety of demands on vendors and an overlap of services from a lack of overarching strategy.
Together, this is creating inefficiency, hindering innovation and adding additional effort to overstretched supply chain leaders. But, there is a way for your vendors to start doing more for you, integrating more effectively with your operations and bringing forward new ideas. It simply requires collaboration.
This is often easier said that done. So we reached out to two industry experts; Bruce Guenter, Director of Logistics and Distribution at Radius Health and Rick Calabrese, Global Director of Corporate Quality Systems at Sartorius. They have shared insight with us on the steps needed to improve your vendor collaboration, how to balance the cost vs quality dynamic and where you can leverage your network to improve collaboration.
If you are interested in keeping your message in the market, generating fresh leads and maintaining strong brand awareness digitally, then check out our Media Kit! Discover how you can utilize our online events, webinars, virtual executive meetings and other services as part of your marketing strategy.
In conjunction with this year’s regional and global forums on time- and temperature-controlled logistics for life sciences, IQPC has conducted a survey involving pharma manufacturers, logistics and transportation providers and packaging developers. The key takeway: the old standby term “cold chain” no longer encompasses the range of services and technologies important to the industry. And despite the flow of new technologies that have been showcased by IQPC since its first global forum, 18 years ago, there is still a strong appetite for innovation and new technology: operational managers believe that a better supply chain for time- and temperature-controlled products is possible.
DOWNLOAD our latest industry report to find out:
Are you new to online events? Don't fret - this guide will walk you through the steps to make the most out of your experience.
Find out who you will meet and learn from this September with our past attendee list. Here are a few of our past attendees:
Download the full list to see more than 100+ job titles and companies that have attended past Cold Chain Global Forums
If you would like a copy of the Past Attendee List sent directly to you, please contact us here.
Have you heard the buzz? The Temperature Control and Logistics U.S. Summit, formerly known as the Annual Cold Chain Global Forum, is back in Boston.
As we kick off the new year, check out our 2019 Post Show Report to find out what you missed last time around. This event recap includes:
Event Details: September 22-25, 2020 | Sheraton Boston, MA